United Asset Strategies’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,215
Closed -$313K 220
2020
Q3
$313K Sell
3,215
-440
-12% -$50.6K 0.06% 163
2020
Q2
$449K Sell
3,655
-478
-12% -$54.2K 0.09% 134
2020
Q1
$362K Sell
4,133
-35
-0.8% -$3.71K 0.09% 138
2019
Q4
$436K Buy
+4,168
New +$467K 0.08% 159
2015
Q1
Sell
-14,278
Closed -$966K 138
2014
Q4
$966K Buy
+14,278
New +$1.04M 0.41% 65

Other funds holding GWPH

United Asset Strategies's GWPH Position: Q4 2020 in Review

United Asset Strategies sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 3,215 shares — an estimated $313K sold.

United Asset Strategies first reported a position in GWPH in Q4 2014 and held it in 5 quarters. The position peaked at $966K in Q4 2014. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • United Asset Strategies reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • United Asset Strategies sold 3,215 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $313K.
  • United Asset Strategies first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 5 quarters.
  • United Asset Strategies's GW Pharmaceuticals Plc American Depositary Shares position peaked at $966K in Q4 2014.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on United Asset Strategies's 13F filing for Q4 2020, filed 5 Feb 2021.